Next Article in Journal
Metagenomic Analysis of the Respiratory Microbiome of a Broiler Flock from Hatching to Processing
Next Article in Special Issue
Detection of KPC, NDM and VIM-Producing Organisms Directly from Rectal Swabs by a Multiplex Lateral Flow Immunoassay
Previous Article in Journal
Absence of 4-Formylaminooxyvinylglycine Production by Pseudomonas fluorescens WH6 Results in Resource Reallocation from Secondary Metabolite Production to Rhizocompetence
Previous Article in Special Issue
Epidemic HI2 Plasmids Mobilising the Carbapenemase Gene blaIMP-4 in Australian Clinical Samples Identified in Multiple Sublineages of Escherichia coli ST216 Colonising Silver Gulls
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Microorganisms
Volume 9
Issue 4
10.3390/microorganisms9040720
microorganisms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Detection of a New Resistance-Mediating Plasmid Chimera in a blaOXA-48-Positive Klebsiella pneumoniae Strain at a German University Hospital

by
Julian Schwanbeck
1,†,
Wolfgang Bohne
1,†,
Ufuk Hasdemir
2,
Uwe Groß
1,
Yvonne Pfeifer
3,
Boyke Bunk
4,
Thomas Riedel
4,5,
Cathrin Spröer
4,
Jörg Overmann
4,5,
Hagen Frickmann
6,7,‡ and
Andreas E. Zautner
1,*,‡
1
Institute for Medical Microbiology, University Medical Center Göttingen, 37075 Göttingen, Germany
2
Department of Medical Microbiology, School of Medicine, Marmara University, 34854 Istanbul, Turkey
3
Robert Koch Institute, FG13 Nosocomial Infections and Antibiotic Resistance, 38855 Wernigerode, Germany
4
Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, 38124 Braunschweig, Germany
5
German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany
6
Department of Microbiology and Hospital Hygiene, Bundeswehr Hospital Hamburg, 20359 Hamburg, Germany
7
Institute for Medical Microbiology, Virology and Hygiene, University Medicine Rostock, 18057 Rostock, Germany
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
‡
These authors contributed equally to this work.
Microorganisms 2021, 9(4), 720; https://doi.org/10.3390/microorganisms9040720
Submission received: 17 March 2021 / Revised: 25 March 2021 / Accepted: 26 March 2021 / Published: 31 March 2021
(This article belongs to the Special Issue Molecular Epidemiology of Antimicrobial Resistance)
Browse Figures
Versions Notes

Abstract

:
Mobile genetic elements, such as plasmids, facilitate the spread of antibiotic resistance genes in Enterobacterales. In line with this, we investigated the plasmid-resistome of seven blaOXA-48 gene-carrying Klebsiella pneumoniae isolates, which were isolated between 2013 and 2014 at the University Medical Center in Göttingen, Germany. All isolates were subjected to complete genome sequencing including the reconstruction of entire plasmid sequences. In addition, phenotypic resistance testing was conducted. The seven isolates comprised both disease-associated isolates and colonizers isolated from five patients. They fell into two clusters of three sequence type (ST)101 and two ST11 isolates, respectively; and ST15 and ST23 singletons. The seven isolates harbored various plasmids of the incompatibility (Inc) groups IncF, IncL/M, IncN, IncR, and a novel plasmid chimera. All blaOXA-48 genes were encoded on the IncL/M plasmids. Of note, distinct phenotypical resistance patterns associated with different sets of resistance genes encoded by IncL/M and IncR plasmids were observed among isolates of the ST101 cluster in spite of high phylogenetic relatedness of the bacterial chromosomes, suggesting nosocomial transmission. This highlights the importance of plasmid uptake and plasmid recombination events for the fast generation of resistance variability after clonal transmission. In conclusion, this study contributes a piece in the puzzle of molecular epidemiology of resistance gene-carrying plasmids in K. pneumoniae in Germany.

1. Introduction

Plasmids play a major role as causative entities of acquired antimicrobial resistance in Gram-negative bacteria. In particular, horizontal spread of antimicrobial resistance is frequently driven by the conjugation-based transmission of plasmids [1]. Although the replication of resistance-mediating plasmids is associated with fitness costs for bacterial pathogens [2], compensatory mutations alleviate the associated evolutionary disadvantages [1,3]. Adaptive mutations in intergenic regions and selection of genes involved in anaerobic metabolism are thought to specifically stabilize the persistence of plasmid-carrying bacteria in the intestine of colonized individuals [4].
Due to the significant public health impact of plasmid-mediated resistance transfer, bioinformatic solutions for the identification of plasmid sequences from next generation sequence data obtained from bacterial pathogens with acquired resistances were introduced early on [5]. In particular, long read (PacBio) sequencing has proven to be a particularly suitable tool to completely resolve the DNA sequence of extrachromosomal mobile genetic elements like plasmids [6,7]. These methods can be used for the assessment of abundance, quantity, and diversity of plasmids in whole microbial communities.
In microbial species like Escherichia coli and Klebsiella pneumoniae, multidrug-resistance is mainly associated with acquisition and maintenance of plasmids encoding the resistance genes [4]. The geographic distribution patterns of plasmids suggests that special plasmid families are particularly successful in the global spreading of resistance genes. So-called epidemic resistance plasmids comprise plasmids of incompatibility (Inc) groups IncFII, IncA/C, IncL/M, IncN, and IncI1; these carry genes that encode for extended-spectrum β-lactamases (ESBLs), AmpC β-lactamases, and carbapenemases. All of these cephalosporin and carbapenem hydrolyzing enzymes have been globally identified in Enterobacterales of different sources and origins [8].
IncF plasmids have been reported to be associated with the global spread of K. pneumoniae producing CTX-M-15 ESBL [9,10], Klebsiella pneumoniae carbapenemases (KPCs) [11,12,13,14,15], and New Delhi metallo-β-lactamases (NDM) [16]. Their size and the number of replicons is heterogeneous. Replicon sequence typing has been applied for their further characterization [17]. IncL/M plasmids are associated with the carriage of blaOXA-48 carbapenemase genes [18,19]. Thereby, the blaOXA-48 gene has been reported to be specifically encoded on the IncL sequence [10,20]. Although IncL/M plasmids are predominantly prevalent in the Mediterranean region and Western Europe [21], their global spread has been confirmed by identifications even in tropical Brazil [22]. Moreover, IncN-plasmids have also been described to be widely distributed in K. pneumoniae [16,23,24] and to harbor resistance genes, such as blaCTX-M-1 [25], blaKPC [26] and blaIMP-6 [27], respectively. Closely related to IncF plasmids, IncF/IncR-plasmids encoding blaKPC have been reported [14]. Similar to IncF plasmids, IncR plasmids have also been associated with blaKPC genes [28,29] and blaNDM genes [30,31], among other resistance-mediating genes [32,33,34]. The blaKPC gene-association has also been proven for plasmid chimerae with IncR-elements [35].
In 2013–2014, the nosocomial transmission of an oxacillinase-48 (OXA-48) carbapenemase producing K. pneumoniae strain of sequence type (ST)147 was detected at the University Medical Center Göttingen, Germany. During these investigations, seven further isolates of four different STs were identified [36]. Here, we characterize the plasmid-based acquired resistome of these seven blaOXA-48-carrying K. pneumoniae isolates. This explorative assessment will contribute a piece to the puzzle of local resistance epidemiology.

2. Materials and Methods

2.1. Bacterial Isolates and Clinical Information

Seven blaOXA-48-positive clinical K. pneumoniae isolates, which were isolated from five patients at the diagnostic laboratory of the University Medical Center Göttingen, Germany between 2013 and 2014, were included in the plasmid-resistome analysis. During a previous epidemiological assessment, multilocus sequence typing (MLST) assigned three isolates from two patients to sequence type ST101, two isolates from one patient to ST11, and two isolates from two patients to ST23 and ST15 [36]. Clinical information provided for the otherwise fully anonymized isolates comprised patient sex, patient age, site of isolation, and underlying medical condition (Table 1).

2.2. Species Identification and Resistance

Bacterial species identification was performed using the MALDI (Matrix-Assisted Laser Desorption/Ionization) Biotyper system (Bruker Daltonics, Bremen, Germany). Results with MALDI Biotyper identification score values ≥ 2.000 were assessed as correct.
Antimicrobial susceptibilities to 17 antibiotics (piperacillin, piperacillin/tazobactam, cefepime, aztreonam, cefotaxime, ceftazidime, imipenem, meropenem, gentamicin, amikacin, tobramycin, trimethoprim-sulfamethoxazole, colistin, fosfomycin, ciprofloxacin, moxifloxacin, and tigecycline) were assessed using VITEK 2 card AST N248 (bioMérieux, Hilden, Germany). Interpretation was performed according to the recommendations of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints version v11.0 (http://www.eucast.org/clinical_breakpoints, last accessed on 10 February 2021). Transfer of resistance was tested in broth mating experiments; the sodium azide-resistant strain E. coli J53 Azir served as the recipient. Transconjugants were selected on LB agar plates containing sodium azide (200 mg/L), ampicillin (30 mg/L), and a disk with imipenem (10 µg). Antimicrobial susceptibilities and presence of β-lactamase genes were tested, and plasmid content and sizes were determined by S1-nuclease restriction and pulsed-field gel electrophoresis (PFGE) as described before [37].

2.3. Whole Genome Sequencing and Bioinformatics

The seven isolates were identified as carbapenemase producers that harbored carbapenemase gene blaOXA-48, and genome sequence information was generated as described previously [36]. In brief, DNA extractions were subjected to Single-molecule real-time (SMRT) sequencing on a PacBio RSII (Pacific Biosciences, Menlo Park, CA, USA). Using the same DNA preparation, short-read sequencing was performed on a HiSeq 2500 device (Illumina Inc., San Diego, CA, USA). SMRT cell data were assembled independently using the RS_HGAP_Assembly.3 protocol. Briefly, each replicon was circularized independently and the artificial redundancies at the ends of the contigs were removed. The validity of the assembly was checked using the RS_Bridgemapper.1 protocol. Each genome was corrected for indel errors by a mapping of Illumina short-reads onto the SMRT long-read assembled genomes. A consensus concordance of QV60 could be confirmed for all genomes. The assembled genomes were deposited at GenBank. The accession numbers are listed in Table 3 and Table A1. Assembled plasmid contigs were subjected to BLASTN search at the National Center for Biotechnology Information (https://blast.ncbi.nlm.nih.gov/Blast.cgi, accessed on 17 June 2019). The annotation of the assembled genomes was performed applying ‘rapid annotations using subsystems technology’ (RAST) (http://rast.nmpdr.org, accessed on 17 June 2019). Annotated genomes were scanned in the SEED viewer (https://seed-viewer.theseed.org/, accessed on 5 June 2016). Spreadsheet charts with protein coding genes (CDS) were obtained and analyzed for antibiotic resistance genes (ARGs) and mobile genetic elements (MGEs). In addition, the completely assembled genomes in fasta format were provided as inputs to the web-based ResFinder 2.1 tool (http://cge.cbs.dtu.dk/services/ResFinder/, accessed on 22 December 2016) and ARGs identities were accepted at an increased identity threshold of >96% and a min length of 60% [36].

2.4. Plasmid Visualization

Alignment results from BLASTN were visualized using Kablammo (http://kablammo.wasmuthlab.org/, accessed on 15 February 2021), with minimal bit score set to 2000. Single plasmid maps were generated using Geneious Prime v2021.0.3 (Biomatters Ltd., Auckland, New Zealand).

3. Results

3.1. Clinical Information

The seven K. pneumoniae isolates were from five male patients between 31 and 53 years of age. The isolates comprised etiologically relevant isolates from urine in case of urinary tract infection (n = 2), from tracheal secretion in case of pneumonia (n = 1) and from wounds in case of wound infections (n = 2). Furthermore, two ST11 isolates were mere colonizers as detected by hygiene-related routine swabbing (Table 1). Of note, the two isolates from patient 3 were isolated in a temporal distance of about one month. Core genome MLST that was performed in a previous study [36] revealed close genetic relationship of the three ST101 isolates and the two ST11 isolates, respectively.

3.2. Antibiotic Resistance Assessment and Transferability

All seven isolates were resistant to piperacillin, piperacillin/tazobactam, aztreonam, cefotaxime, ceftazidime, gentamicin, tobramycin, ciprofloxacin, moxifloxacin, and trimethoprim-sulfamethoxazole. Resistance and reduced susceptibility to imipenem (range between 0.5 and >8 mg/L) and meropenem (range between 1 and >8 mg/L) was detected for all seven isolates, and the two ST11 isolates were additionally resistant to colistin (Table 2). For two isolates (Kp_Goe_121641—ST101 and Kp_Goe_39795—ST15) the broth mating experiment were successful. The obtained transconjugants were positive for blaOXA-48, were resistant to piperacillin and MICs of 1–2 mg/L were detected for imipenem and meropenem. S1-nuclease pulsed field gel electrophoresis (PFGE) showed the presence of a plasmid of ca. 60 kb size in the transconjugants (Appendix B Figure A1).

3.3. Analysis of the Plasmids and Comparison with Phenotypical Resistance

As visualized in Figure 1, Figure 2 and Figure 3, and in Table 3, numerous resistance genes occurred in various types of plasmids of the lineages IncL/M, IncR, IncF, and IncN. Each isolate had at least two different types of plasmids, one of which was IncL/M with blaOXA-48 (example: Figure 1A).
The resistance gene blaOXA-48, whose abundance was the selection criterion of the seven isolates for this study, was exclusively associated with IncL/M plasmids of variable size; plasmid pKp_Goe_795-2 of ST15 isolate Kp_Goe_39795 is shown exemplarily in Figure 1A. These plasmids, however, further hosted additional antibiotic resistance genes (ARGs) besides blaOXA-48 gene in two out of three isolates of ST101 (Table 3). In five isolates (Kp_Goe_121641, Kp_Goe_821588, Kp_Goe_822917, Kp_Goe_154414, Kp_Goe_39795), the IncL/M plasmids showed 100% identity with the reference plasmid pOXA-48 (GenBank accession number: JN626286). Complete sequences of these plasmids were similar to each other above the 99.9% level, but were also similar to some other plasmids in enterobacterial species collected from the same region and other countries (Appendix A Table A1). In contrast, the IncL/M plasmids of the two ST101 isolates from patient 1 (Kp_Goe_33208 and Kp_Goe_71070) showed 99.59% identity with the K. pneumoniae plasmid pMU407 (GenBank accession number: U27345). The identity between the complete sequences of these two plasmids was 100%. In contrast to the third ST101 isolate from patient 2, further resistance genes (e.g., ESBL gene blaCTX-M-14b and plasmid mediated quinolone resistance determinants qnrS1/9) were located on the IncL/M plasmid with blaOXA-48 (Table 3, Figure 4). The comparative BLAST analysis of complete sequences also revealed 100% identity with a 90% query coverage to a plasmid (GenBank accession number: KP025948) from a Proteus mirabilis strain (Appendix A Table A1) [38].
Analysis of the genetic synteny of the blaOXA-48 gene revealed its location within an element of transposon Tn1999.2 in the two IncL/M plasmids of ST101 isolates (Kp_Goe_33208 and Kp_Goe_71070). The blaOXA-48 gene was flanked by lysR and IS1999, respectively, downstream and by IS1R and IS1 upstream. On the other hand, McmM, TrbN, TrbB, and TrbA encoding genes were found downstream of Tn1999 in pOXA-48 type IncL/M plasmids of the other five isolates (Figure 5).
As indicated in Figure 3 and Table 3, the ST15 isolate Kp_Goe-39795 carried a large 232kb plasmid chimera that has not been described before. This IncF plasmid (Figure 3) with FIB replicon did not show similarity with any known plasmid in BLAST analysis. It encoded the ARGs blaCTX-M-15, blaOXA-1, blaTEM-1, aac(6′)-Ib-cr, aac(3)-IIa, aph(6)-Id, aph(3″)-Ib, ant(3″)-Ia, catB3, catA1, sul2, tetA, as well as various heavy metal resistance determinants. The mobile genetic elements flanked by these genes are shown in Table 3. Individual parts of this plasmid chimera could be matched to putative origin plasmids (Figure 3). GenBank accession numbers of all detected plasmids in the seven K. pneumoniae isolates are shown in Appendix A Table A1.
In four out of seven isolates, IncF plasmids were present (Table 3); these carried various genes that mediate resistance to β-lactams, aminoglycosides, phenicols, tetracyclines, sulfonamides and trimethoprim. The presence of these genes corresponded with the observed phenotypes. Examples for reconstructed IncF plasmids are given in Figure 1B and Figure 2A. IncFII, IncFIB, and IncFIA replicons were detected on these plasmids (Appendix A Table A1). The complete sequences of the IncF plasmids of the two ST11 isolates Kp_Goe_821588 and Kp_Goe_822917 were identical to each other. These plasmids carried both FII and FIB replicons, resistance genes blaCTX-M-15, blaOXA-1, aac(6′)-Ib-cr, aac(3)-IIa, aph(3′)-Ia, catB3, dfrA14, and genes mediating resistance to heavy metals, such as arsenic, cobalt, zinc, cadmium and copper (Table 3). Kp_Goe_154414 (ST 23) had four IncF type plasmids. Three out of them harbored several ArGs encoding resistance to β-lactams, aminoglycosides, quinolones, phenicols, sulfonamides, tetracycline, and heavy metals (Table 3).
In three ST101 isolates (Kp_Goe_33208 (Figure 1C), Kp_Goe_71070, and Kp_Goe_121641), IncR plasmids carried a composition of ARGs similar to those found on the IncF plasmids, one example is given in Figure 1B. The backbones of these plasmids were 100% identical with the plasmid pK245 (Gene accession number: DQ449578). The complete sequences of the IncR plasmids of isolates from patient 1 (Kp_Goe_33208 and Kp_Goe_71070) were identical to each other. Their identity with the smaller IncR plasmid of Kp_Goe_121641 was 99.99% with a coverage of 74%. The resistance genes cat, ant(3″)-Ia, aac(6′)-Ib, aac(6′)-Ib-cr, aac(3)-IIa, blaTEM-1A, blaOXA-9, dfrA14, merE, merT, merC were detected in all IncR plasmids (Table 3). In addition to this, tetA, tetD, mph(A), emrE, sul3, cmlA, and floR were located on the IncR plasmids of the isolates Kp_Goe_33208 and Kp_Goe_71070 compared to Kp_Goe_121641 (Table 3). The additional ArGs on the IncR plasmid of isolate Kp_Goe_121641 included β-lactamase genes blaCTX-M-15 and blaOXA-1. The blaCTX-M-15 gene was flanked downstream by insA and IS1 and upstream by the tryptophan synthase coding gene and IS1 (Figure 4B).
An IncN plasmid was detected in one of the two K. pneumoniae-ST11 isolates from patient 3 (Kp_Goe_822917), associated with a number of genes that mediate resistance to macrolides, trimethoprim and ethidium bromide (Figure 2B, Table 3).

4. Discussion

The study was performed to contribute to the existing epidemiological knowledge on the distribution of antibiotic resistance-mediating plasmids in carbapenemase producing K. pneumoniae isolates in Germany. The characterized seven isolates represent epidemic clonal lineages of K. pneumoniae (ST11, ST15, ST101, and ST23) that have been described worldwide and are associated with multidrug resistance and/or enhanced virulence [39]. The genetic relationship of these bacterial isolates has been first characterized in detail in a previous study [36]. To allow an unambiguous attribution of the described plasmids to the previously described bacterial isolates, the specific identifier codes Kp_Goe_xxxxx are identical in the previous manuscript [36] and in the present one.
As expected, the so-called epidemic resistance plasmids IncF, IncL/M, and IncN [8] that carry various resistance-mediating genes were identified in these seven isolates. Furthermore, we identified IncR plasmids and a new IncF (FIB) plasmid chimera.
As reported by others, the blaOXA-48 genes waere associated with IncL/M plasmids [10,18,19,20]. As typical for blaOXA-48, which is only associated with high-level carbapenem resistance in case of combination with other resistance mediating elements [18], the majority of the seven K. pneumoniae isolates were phenotypically tested susceptible towards carbapenems (Table 2).
The tracking of carbapenem resistance-associated mechanisms remains an issue of relevance, as infections, due to carbapenem-resistant K. pneumoniae, are globally reported, and are rising [40,41,42]. Thereby, plasmid-encoded carbapenemase production is the major mechanism of carbapenem resistance in K. pneumoniae. While mobile genetic elements such as plasmids, transposons, and insertion sequences readily enable the transmission of carbapenemase-encoding genes, clonal expansion contributes to the globally increasing rates of dissemination of carbapenemase-producing K. pneumoniae [40,41,42]. Next to transmission events within human microbiomes, spread of resistance determinants may also occur in external environments under the selection pressure of pollution with antimicrobial active substances [43].
Our seven study isolates, which included both disease-associated and merely colonizing isolates, were associated with the carriage of resistance-mediating plasmids. As shown for the phylogenetically closely related isolates of the sequence type ST101 (confirmed by cgMLST [36]) indicating likely nosocomial transmission, their accessory genome varied remarkably. Cause of such variance is a different set of resistance mediating plasmids, encoding various resistance determinants (Table 3) that may create phenotypical variations. Discrepancies in phenotypical resistance does therefore not necessarily exclude nosocomial spread. However, isolates from the same patients showed identical phenotypic resistance in our study, although variations in plasmid content were detected for two ST11 isolates (Table 3).
While carbapenem resistance, or at least reduced carbapenem susceptibility compared to the wild type, was associated with blaOXA-48 in all cases, this resistance gene is not the only one that has been frequently detected in K. pneumoniae. In the early 2000s, three types of carbapenemases, Klebsiella pneumoniae carbapenemase (KPC), oxacillinase-48 (OXA-48) type carbapenemase, and the New Delhi metallo-β-lactamase (NDM), emerged globally and spread rapidly. Nosocomial outbreaks due to carbapenemase producing K. pneumoniae strains became an alarming issue in hospital setting in many countries in Europe and worldwide [40,41,42]. To cite some examples, IncF plasmids with the IncFIIK replicon mediated the global spread of KPC-encoding genes throughout the United States, Colombia, Argentina, Israel, Greece, Norway, Sweden, Italy, Poland, Canada, Brazil, Korea, and Taiwan [40,41,42]. Starting at the Indian subcontinent, New Delhi metallo-β-lactamase producing K. pneumoniae have rapidly spread to various countries such as Romania, Poland, Hungary, Denmark, Italy, Spain, Greece, Turkey, China, Australia, Japan, Colombia, South Africa, Algeria, Morocco, Saudi Arabia, and Oman [40,41,42] in association with the plasmids IncA/C, IncFII, IncN, IncH, and IncL/M. In contrast, OXA-48 producing K. pneumoniae, such as those examined in the presented study, were first identified in Turkey in 2001 and showed a rapid global dissemination [40,41,42,44]. Just as shown for the ST11 isolates in our study, blaOXA-48, encoding the OXA-48 carbapenemase, was first identified as a part of Tn1999 on an IncL/M plasmid, pOXA-48a (GenBank accession number JN626286). As observed for the isolates presented here, the global dissemination of blaOXA-48 in K. pneumoniae has been mainly linked to the epidemic IncL/M plasmid [10,18,19,20]. The variant of Tn1999, Tn1999.2, which was observed in two of the analyzed ST101 isolates, has been detected in K. pneumoniae carrying blaOXA-48 together with blaCTX-M-14-b and other antimicrobial resistance genes, while other authors reported the association of blaOXA-48 together with blaCTX-M-15 [45]. While the IncL/M plasmid was the genetic element primarily responsible for reduced carbapenem susceptibility or carbapenem resistance in our isolates, the other detected IncF, IncN, and IncR plasmids carried various resistance genes and contributed to their multidrug-resistance phenotype (Table 3).
The observation of the new plasmid chimera pKp_Goe_795-1 (CP018460, Figure 3) is of particular interest, as it documents “real life evolution” by the assembly of resistance determinants in one, and the same plasmid vector through extensive transposition. Associated with this process, it is worth focusing on the epidemiological background of transposases and other ARG-associated mobile genetic elements (MGEs) found in the genetic information of the plasmid chimera (Table 3). The reported IS6 insertion sequence family has previously been reported from a multidrug resistance-mediating plasmid in Proteus mirabilis in China [46]. IS6 also allowed migration of a replicative elements carrying ARGs by replicative transposition in Klebsiella pneumoniae in France and in Japan [47,48]. Tn3-like transposons have recently been reported from Enterobacterales including K. pneumoniae from China and Switzerland [49,50,51]. The transition protein-encoding tnp1 has been described from E. coli in China [52]. The insertion sequence IS1380 has been first identified in Acinetobacter pasteurianus [53,54], the insertion sequence IS110 was recently reported from Klebsiella pneumoniae from New Jersey [55], IS1 in K. pneumoniae from China and Russia [56,57], IS481 in K. pneumoniae from Japan [48], IS903 in K. pneumoniae from France and China [58,59], and in Salmonellae from the USA [60]. IS66 is abundant in the worldwide-distributed K. pneumoniae sequence types ST258/ST512 [61]. IS3, using a two-step transposition mechanism to specifically insert into short palindromic repeated sequences, has been reported from K. pneumoniae in Europe and the USA [62,63,64]. IntIPac was described from a IncFIB plasmid found in a clinical Klebsiella variicola isolate in Hong Kong [65]. A new member of the insertion sequence family ISNCY has been reported from K. pneumoniae in California, USA, some years ago [63]. The insertion sequence ISL3 has been linked to the transposition of sequence information for colistin resistance in Europe [66] and for carbapenem resistance in China [67] in K. pneumoniae. Summarized, the observed MGEs are internationally common in Enterobacterales in general and K. pneumoniae in particular, while just the arrangement in the newly described plasmid has not yet been described so far.
The limited number of assessed isolates is the major limitation of this study presented here. Nevertheless, the presented data provide a piece in the puzzle of molecular epidemiology of resistance-mediating plasmids in Germany. It contributes to previous efforts to improve our understanding how blaOXA-48 and other antimicrobial resistance genes spread among K. pneumoniae isolates [36,68,69].

5. Conclusions

The study demonstrated the abundance of various IncF, IncM/L, IncN, and IncR plasmids in seven OXA-48 producing K. pneumoniae isolates from hospitalized patients in Germany. Long read sequencing enabled the complete plasmid reconstruction and identification of a novel IncF (FIB) plasmid chimera. It further highlighted the association of blaOXA-48 with IncL/M plasmids in K. pneumoniae. This information, once implemented in bioinformatics tools for molecular identification of antibiotic resistance, will help to improve the molecular epidemiology of resistance plasmids and resistance genes. Thus, it contributes to the prediction of phenotypic susceptibilities and improve our understanding of the evolution of resistance gene-encoding plasmids. Future challenges for the goal of achieving broad surveillance of resistance-mediating MGEs comprise ready and affordable availability of sequencing technology and lacking automation of bioinformatic assessments, which is still associated with an unrealistically high work-load for application under routine-diagnostic conditions. Further declines of sequencing costs and increased implementation of artificial intelligence (AI) solutions in order to reduce the required hands-on time of experts may guide the way to achieve molecular near-real-time surveillance in the future.

Author Contributions

Conceptualization, W.B. and A.E.Z.; methodology, W.B., H.F., A.E.Z.; software, J.S., U.H., B.B., T.R.; validation, W.B., A.E.Z., and J.O.; formal analysis, B.B., T.R., U.H., J.O.; investigation, Y.P., C.S.; resources, U.G., J.O.; data curation, B.B., T.R.; writing—original draft preparation, H.F., A.E.Z., J.S.; writing—review and editing, J.S., W.B., U.H., U.G., Y.P., B.B., T.R., C.S., H.F., A.E.Z.; visualization, J.S., U.H.; supervision, A.E.Z., W.B.; project administration, W.B, U.G.; funding acquisition, U.G. All authors have read and agreed to the published version of the manuscript.

Funding

The APC was funded by the Open Access Support Program of the Deutsche Forschungsgemeinschaft and the publication fund of the Georg-August-Universität Göttingen.

Data Availability Statement

All relevant data are provided in the paper. The bacterial genomes have been deposited at NCBI GenBank and can be accessed via the accession numbers given in the article.

Acknowledgments

We thank Simone Severitt and Nicole Heyer for excellent technical assistance, as well as Jolantha Swiderski for bioinformatics assistance in genome assembly.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Table
Table A1. GenBank Accession numbers and BLAST results of the plasmids of Klebsiella pneumoniae isolates on the basis of PlasmidFinder-2.0 of Center for Genomic Epidemiology (CGE) and National Center for Biotechnology Information (NCBI).
Table A1. GenBank Accession numbers and BLAST results of the plasmids of Klebsiella pneumoniae isolates on the basis of PlasmidFinder-2.0 of Center for Genomic Epidemiology (CGE) and National Center for Biotechnology Information (NCBI).
Plasmid FinderNCBI
PlasmidAccession No.Identity (%)Identity with (Accession No.)Query Coverage (%)Identity (%)Identity with Plasmid (Accession No.)
Kp_Goe_33208IncL/MCP01844999.59pMU407.1 (U27345)90100pOXA-48-pm (KP025948)
87100pEC743 (CP015071)
8498.85pKpvST383L (CP034202)
8399.94pJEG011 (KC354801)
IncRCP018448100pK245 (DQ449578)7999.94unnamed plasmid (CP032176)
74100pKp_Goe_641-1 (CP018737)
10099.99pKp_Goe_070-1 (CP018451)
Kp_Goe_71070IncL/MCP01845299.59pMU407.1 (U27345)90100pOXA-48-pm (KP025948)
87100pEC743 (CP015071)
8498.85pKpvST383L (CP034202)
8399.94pJEG011 (KC354801)
IncRCP018451100pK245 (DQ449578)7999.92unnamed plasmid (CP032176)
7499.99pKp_Goe_641-1 (CP018737)
100100pKp_Goe_208-1 (CP018448)
Kp_Goe_121641IncL/MCP018736100pOXA-48 (JN626286)100100pOXA-48_A12536 (LR025100)
100100pOXA-48_E7215 (LR025098)
100100pOXA-48_980 (LR025091)
100100pOXA-48_920 (LR025095)
>99>99.91pKp_Goe_579_1, pKp_Goe_832-1, pKp_Goe_414-5, pKp_Goe_024, pKp_Goe_795-2, pKp_Goe_021-1, pKp_Goe_026-1
IncRCP018737100pK245 (DQ449578)91100pKp_Goe_208-1 (CP018448)
9199.99pKp_Goe_070-1 (CP018451)
58100pKPN101-IT (JX283456)
Kp_Goe_821588IncL/MCP018694100pOXA-48 (JN626286)10099.98pOXA-48_L111 (CP030135)
10099.98pKPN-E1.Nr7 (KM406491)
10099.95pEC745_OXA-48 (CP015075)
100100Kp_Goe_121641, Kp_Goe822917, Kp_Goe_154414
10099.99pKp_Goe_795-2 (CP018461.1)
100100Kp_Goe_152021, Kp_Goe_827026, Kp_Goe_149473, Kp_Goe_828304, Kp_Goe_822917, Kp_Goe_827024, Kp_Goe_149832, Kp_Goe_822579
IncF (FII + FIB)CP018693100pKPN3 (CP000648)100100pKp_Goe_917-1 (CP018441)
94100plasmid IncFIB IncFII (CP027037)
91100plasmid p1 (CP006657)
Kp_Goe_822917IncL/MCP018443100pOXA-48 (JN626286)100100Kp_Goe_821588, Kp_Goe_154414, Kp_Goe_39795
100100Kp_Goe_152021, Kp_Goe_149473, Kp_Goe_827026, Kp_Goe_828304, Kp_Goe_827024, Kp_Goe_149832, Kp_Goe_822579
plasmid IncLM (CP027039)
IncF (FIB + FII)CP018441100 (FIB)pKPN-IT (JN233704)100100CP018693, Kp_Goe_821588
100 (FII)pKPN3 (CP000648)94100plasmid IncFIB IncFII (CP027037)
91100plasmid p1 (CP006657)
9399.98pKp_Goe_629-1 (CP018365)
IncNCP018442 9299.99plasmid pOW16C2 (KF977034)
9097.72pNL194 (GU585907)
Kp_Goe_39795IncL/MCP018461100pOXA-48 (JN626286)10099.99pOXA-48_L111 (CP030135)
10099.97pKPN-E1.Nr7 (KM406491)
100100pKp_Goe_121641, pKp_Goe_821588
100100pKp_Goe_828304, pKp_Goe_149473, pKp_Goe_152021, pKp_Goe_827026,
IncF (FIBK)CP018460100pKPN3 (JN233704)--New (this study)
IncF(FII)CP018462100pC15-1a (AY458016)8299.98pKp_Goe_414-1 (CP018143)
10099.98Plasmid unnamed3 (CP034056)
10099.97pEK516 (EU935738)
10099.98pC15-1a (AY458016)
Kp_Goe_154414IncL/MCP018342100pKPN3 (JN233704)100100Plasmid unnamed2 (CP032174)
100100pOXA-48 (LR025105)
100100pOXA-48 (LR025091)
10099.99pKp_Goe_641-2 (CP018736)
10099.99pKp_Goe_827024, pKp_Goe_149832, pKp_Goe_822579, pKp_Goe_827026, pKp_Goe_152021, pKp_Goe_149473, pKp_Goe_828304
IncF(FIB)CP01833899.54pNDM-MAR (JN420336)9599.88plasmid F81 (CP026166)
9299.76plasmid L22-1 (CP031258)
10099.99pVir_095132 (CP028390)
10099.99Goe-827024, 149832, 822579, 827026, 152021, 149473, 828304,121641
IncF(FII)CP018343100pC15-1a (AY458016)9599.83K. pneumoniae KP_NORM_BLD_2015_112126
plasmid unnamed3 (CP034056)
8499.99K. pneumoniae M16-13 plasmid
pM16-13 (KY751925)
9599.99K. pneumoniae strain NY9
plasmid pNY9_3 (CP015388)
IncFIIKCP01834198.65pKPN3 (CP000648)10099.97K. pneumoniae p4-L388, ST11 KPC-1 producer, 2018 China (CP029223)
10099.97K. pneumoniae pQnr-S1_020079, 2018 China (CP029382)
9899.97K. pneumoniae plasmid p3s1, 2018, China (CP034126)
IncF(FIA)CP01834097.16R27 plasmid (AF250878)8399.37pEC25-1 (CP035124)
8199.37pQnrB (CP025966)
8199.37pKPC2_095132 (CP028389)

Appendix B

Microorganisms 09 00720 g0a1 550
Figure A1. Plasmids of seven OXA-48 producing Klebsiella pneumoniae isolates and two Escherichia coli transconjugants visualized by S1-nuclease restriction and pulsed-field gel electrophoresis. Lane 1, K. pneumoniae-ST101 Kp_Goe_33208; lane 2, K. pneumoniae-ST101 Kp_Goe_71070; lane 3, K. pneumoniae-ST101 Kp_Goe_121641; lane 4, K. pneumoniae-ST11 Kp_Goe_821588; lane 5, K. pneumoniae-ST11 Kp_Goe_822917; lane 6, K. pneumoniae-ST23 Kp_Goe_154414; lane 8, Kp_Goe_121641-E. coli J53 transconjugant blaOXA-48-positive; lanes 7 and 9, K. pneumoniae-ST15 Kp_Goe_39795; lane 10, Kp_Goe_39795-E. coli J53 transconjugant blaOXA-48-positive; lane M, Salmonella enterica, serotype Braenderup H9812 (XbaI-restricted).
Figure A1. Plasmids of seven OXA-48 producing Klebsiella pneumoniae isolates and two Escherichia coli transconjugants visualized by S1-nuclease restriction and pulsed-field gel electrophoresis. Lane 1, K. pneumoniae-ST101 Kp_Goe_33208; lane 2, K. pneumoniae-ST101 Kp_Goe_71070; lane 3, K. pneumoniae-ST101 Kp_Goe_121641; lane 4, K. pneumoniae-ST11 Kp_Goe_821588; lane 5, K. pneumoniae-ST11 Kp_Goe_822917; lane 6, K. pneumoniae-ST23 Kp_Goe_154414; lane 8, Kp_Goe_121641-E. coli J53 transconjugant blaOXA-48-positive; lanes 7 and 9, K. pneumoniae-ST15 Kp_Goe_39795; lane 10, Kp_Goe_39795-E. coli J53 transconjugant blaOXA-48-positive; lane M, Salmonella enterica, serotype Braenderup H9812 (XbaI-restricted).
Microorganisms 09 00720 g0a1

References

  1. San Millan, A. Evolution of Plasmid-Mediated Antibiotic Resistance in the Clinical Context. Trends Microbiol. 2018, 26, 978–985. [Google Scholar] [CrossRef] [Green Version]
  2. San Millan, A.; MacLean, R.C. Fitness Costs of Plasmids: A Limit to Plasmid Transmission. Microbiol. Spectr. 2017, 5, 5. [Google Scholar]
  3. Loftie-Eaton, W.; Bashford, K.; Quinn, H.; Dong, K.; Millstein, J.; Hunter, S.; Thomason, M.K.; Merrikh, H.; Ponciano, J.M.; Top, E.M. Compensatory mutations improve general permissiveness to antibiotic resistance plasmids. Nat. Ecol. Evol. 2017, 1, 1354–1363. [Google Scholar] [CrossRef] [PubMed]
  4. Dunn, S.J.; Connor, C.; McNally, A. The evolution and transmission of multi-drug resistant Escherichia coli and Klebsiella pneumoniae: The complexity of clones and plasmids. Curr. Opin. Microbiol. 2019, 51, 51–56. [Google Scholar] [CrossRef] [PubMed]
  5. Carattoli, A.; Zankari, E.; García-Fernández, A.; Voldby Larsen, M.; Lund, O.; Villa, L.; Møller Aarestrup, F.; Hasman, H. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob. Agents Chemother. 2014, 58, 3895–3903. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. De Maio, N.; Shaw, L.P.; Hubbard, A.; George, S.; Sanderson, N.D.; Swann, J.; Wick, R.; AbuOun, M.; Stubberfield, E.; Hoosdally, S.J.; et al. Comparison of long-read sequencing technologies in the hybrid assembly of complex bacterial genomes. Microb. Genom. 2019, 5, e000294. [Google Scholar] [CrossRef] [PubMed]
  7. Suzuki, Y.; Nishijima, S.; Furuta, Y.; Yoshimura, J.; Suda, W.; Oshima, K.; Hattori, M.; Morishita, S. Long-read metagenomic exploration of extrachromosomal mobile genetic elements in the human gut. Microbiome 2019, 7, 119. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Carattoli, A. Plasmids in Gram negatives: Molecular typing of resistance plasmids. Int. J. Med. Microbiol. 2011, 301, 654–658. [Google Scholar] [CrossRef]
  9. Shin, J.; Choi, M.J.; Ko, K.S. Replicon sequence typing of IncF plasmids and the genetic environments of blaCTX-M-15 indicate multiple acquisitions of blaCTX-M-15 in Escherichia coli and Klebsiella pneumoniae isolates from South Korea. J. Antimicrob. Chemother. 2012, 67, 1853–1857. [Google Scholar] [CrossRef] [Green Version]
  10. Machuca, J.; López-Cerero, L.; Fernández-Cuenca, F.; Mora-Navas, L.; Mediavilla-Gradolph, C.; López-Rodríguez, I.; Pascual, Á. OXA-48-Like-Producing Klebsiella pneumoniae in Southern Spain in 2014–2015. Antimicrob. Agents Chemother. 2018, 63, e01396-18. [Google Scholar] [CrossRef] [Green Version]
  11. Zhou, Y.; Tang, Y.; Fu, P.; Tian, D.; Yu, L.; Huang, Y.; Li, G.; Li, M.; Wang, Y.; Yang, Z.; et al. The type I-E CRISPR-Cas system influences the acquisition of bla(KPC)-IncF plasmid in Klebsiella pneumoniae. Emerg. Microbes Infect. 2020, 9, 1011–1022. [Google Scholar] [CrossRef]
  12. Tang, Y.; Fu, P.; Zhou, Y.; Xie, Y.; Jin, J.; Wang, B.; Yu, L.; Huang, Y.; Li, G.; Li, M.; et al. Absence of the type I-E CRISPR-Cas system in Klebsiella pneumoniae clonal complex 258 is associated with dissemination of IncF epidemic resistance plasmids in this clonal complex. J. Antimicrob. Chemother. 2020, 75, 890–895. [Google Scholar] [CrossRef] [PubMed]
  13. Yu, X.; Zhang, W.; Zhao, Z.; Ye, C.; Zhou, S.; Wu, S.; Han, L.; Han, Z.; Ye, H. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae isolates with focus on antimicrobial resistance. BMC Genom. 2019, 20, 822. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Feng, Y.; Liu, L.; McNally, A.; Zong, Z. Coexistence of three bla(KPC-2) genes on an IncF/IncR plasmid in ST11 Klebsiella pneumoniae. J. Glob. Antimicrob. Resist. 2019, 17, 90–93. [Google Scholar] [CrossRef] [PubMed]
  15. Peirano, G.; Bradford, P.A.; Kazmierczak, K.M.; Chen, L.; Kreiswirth, B.N.; Pitout, J.D. Importance of Clonal Complex 258 and IncF(K2-like) Plasmids among a Global Collection of Klebsiella pneumoniae with bla(KPC). Antimicrob. Agents Chemother. 2017, 61, e02610-16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Pérez-Vázquez, M.; Sola Campoy, P.J.; Ortega, A.; Bautista, V.; Monzón, S.; Ruiz-Carrascoso, G.; Mingorance, J.; González-Barberá, E.M.; Gimeno, C.; Aracil, B.; et al. Emergence of NDM-producing Klebsiella pneumoniae and Escherichia coli in Spain: Phylogeny, resistome, virulence and plasmids encoding blaNDM-like genes as determined by WGS. J. Antimicrob. Chemother. 2019, 74, 3489–3496. [Google Scholar] [CrossRef]
  17. Villa, L.; García-Fernández, A.; Fortini, D.; Carattoli, A. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J. Antimicrob. Chemother. 2010, 65, 2518–2529. [Google Scholar] [CrossRef] [Green Version]
  18. Poirel, L.; Potron, A.; Nordmann, P. OXA-48-like carbapenemases: The phantom menace. J. Antimicrob. Chemother. 2012, 67, 1597–1606. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Gaibani, P.; Scaltriti, E.; Benni, C.; Pongolini, S.; Ambretti, S.; Landini, M.P.; Viale, P.; Giannella, M.; Re, M.C. Characterization of an IncL/M plasmid carrying blaOXA-48 in a Klebsiella pneumoniae strain from Italy. New Microbiol. 2017, 40, 284–285. [Google Scholar]
  20. Carattoli, A.; Seiffert, S.N.; Schwendener, S.; Perreten, V.; Endimiani, A. Differentiation of IncL and IncM Plasmids Associated with the Spread of Clinically Relevant Antimicrobial Resistance. PLoS ONE 2015, 10, e0123063. [Google Scholar] [CrossRef] [Green Version]
  21. Adamczuk, M.; Zaleski, P.; Dziewit, L.; Wolinowska, R.; Nieckarz, M.; Wawrzyniak, P.; Kieryl, P.; Plucienniczak, A.; Bartosik, D. Diversity and Global Distribution of IncL/M Plasmids Enabling Horizontal Dissemination of β-Lactam Resistance Genes among the Enterobacteriaceae. BioMed Res. Int. 2015, 2015, 414681. [Google Scholar] [CrossRef] [Green Version]
  22. Oliveira, É.M.; Beltrão, E.M.B.; Scavuzzi, A.M.L.; Barros, J.F.; Lopes, A.C.S. High plasmid variability, and the presence of IncFIB, IncQ, IncA/C, IncHI1B, and IncL/M in clinical isolates of Klebsiella pneumoniae with blaKPC and blaNDM from patients at a public hospital in Brazil. Rev. Soc. Bras. Med. Trop. 2020, 53, e20200397. [Google Scholar] [CrossRef] [PubMed]
  23. Rada, A.M.; De La Cadena, E.; Agudelo, C.; Capataz, C.; Orozco, N.; Pallares, C.; Dinh, A.Q.; Panesso, D.; Ríos, R.; Diaz, L.; et al. Dynamics of bla(KPC-2) Dissemination from Non-CG258 Klebsiella pneumoniae to Other Enterobacterales via IncN Plasmids in an Area of High Endemicity. Antimicrob. Agents. Chemother. 2020, 64, e01743-20. [Google Scholar] [CrossRef]
  24. Aires-de-Sousa, M.; Ortiz de la Rosa, J.M.; Gonçalves, M.L.; Pereira, A.L.; Nordmann, P.; Poirel, L. Epidemiology of Carbapenemase-Producing Klebsiella pneumoniae in a Hospital, Portugal. Emerg. Infect. Dis. 2019, 25, 1632–1638. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Yang, Y.; Higgins, C.H.; Rehman, I.; Galvao, K.N.; Brito, I.L.; Bicalho, M.L.; Song, J.; Wang, H.; Bicalho, R.C. Genomic Diversity, Virulence, and Antimicrobial Resistance of Klebsiella pneumoniae Strains from Cows and Humans. Appl. Environ. Microbiol. 2019, 85, e02654-18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Hao, M.; He, Y.; Zhang, H.; Liao, X.P.; Liu, Y.H.; Sun, J.; Du, H.; Kreiswirth, B.N.; Chen, L. CRISPR-Cas9-Mediated Carbapenemase Gene and Plasmid Curing in Carbapenem-Resistant Enterobacteriaceae. Antimicrob. Agents Chemother. 2020, 64, e00843-20. [Google Scholar] [CrossRef]
  27. García-Fernández, A.; Villa, L.; Moodley, A.; Hasman, H.; Miriagou, V.; Guardabassi, L.; Carattoli, A. Multilocus sequence typing of IncN plasmids. J. Antimicrob. Chemother. 2011, 66, 1987–1991. [Google Scholar] [CrossRef]
  28. Jing, Y.; Jiang, X.; Yin, Z.; Hu, L.; Zhang, Y.; Yang, W.; Yang, H.; Gao, B.; Zhao, Y.; Zhou, D.; et al. Genomic diversification of IncR plasmids from China. J. Glob- Antimicrob. Resist. 2019, 19, 358–364. [Google Scholar] [CrossRef]
  29. Dong, N.; Liu, L.; Zhang, R.; Chen, K.; Xie, M.; Chan, E.W.C.; Chen, S. An IncR Plasmid Harbored by a Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Strain Possesses Five Tandem Repeats of the bla (KPC-2)::NTE(KPC)-Id Fragment. Antimicrob. Agents Chemother. 2019, 63, e01775-18. [Google Scholar] [CrossRef] [Green Version]
  30. Kocsis, E.; Gužvinec, M.; Butić, I.; Krešić, S.; Crnek, S.Š.; Tambić, A.; Cornaglia, G.; Mazzariol, A. blaNDM-1 Carriage on IncR Plasmid in Enterobacteriaceae Strains. Microb. Drug. Resist. 2016, 22, 123–128. [Google Scholar] [CrossRef]
  31. Gamal, D.; Fernández-Martínez, M.; Salem, D.; El-Defrawy, I.; Montes, L.Á.; Ocampo-Sosa, A.A.; Martínez-Martínez, L. Carbapenem-resistant Klebsiella pneumoniae isolates from Egypt containing blaNDM-1 on IncR plasmids and its association with rmtF. Int. J. Infect. Dis. 2016, 43, 17–20. [Google Scholar] [CrossRef] [Green Version]
  32. Qian, C.; Zhu, X.; Lu, J.; Shen, K.; Chen, Q.; Zhou, W.; Liu, H.; Lu, W.; Zhou, D.; Sun, Z.; et al. Characterization of an IncR Plasmid with Two Copies of ISCR-Linked qnrB6 from ST968 Klebsiella pneumoniae. Int. J. Genom. 2020, 2020, 3484328. [Google Scholar] [CrossRef] [PubMed]
  33. Guo, Q.; Spychala, C.N.; McElheny, C.L.; Doi, Y. Comparative analysis of an IncR plasmid carrying armA, blaDHA-1 and qnrB4 from Klebsiella pneumoniae ST37 isolates. J. Antimicrob. Chemother. 2016, 71, 882–886. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Compain, F.; Frangeul, L.; Drieux, L.; Verdet, C.; Brisse, S.; Arlet, G.; Decré, D. Complete nucleotide sequence of two multidrug-resistant IncR plasmids from Klebsiella pneumoniae. Antimicrob. Agents. Chemother. 2014, 58, 4207–4210. [Google Scholar] [CrossRef] [Green Version]
  35. Qu, D.; Shen, Y.; Hu, L.; Jiang, X.; Yin, Z.; Gao, B.; Zhao, Y.; Yang, W.; Yang, H.; Han, J.; et al. Comparative analysis of KPC-2-encoding chimera plasmids with multi-replicon IncR:Inc(pA1763-KPC):IncN1 or IncFII(pHN7A8):Inc(pA1763-KPC):IncN1. Infect. Drug. Resist. 2019, 12, 285–296. [Google Scholar] [CrossRef] [Green Version]
  36. Zautner, A.E.; Bunk, B.; Pfeifer, Y.; Spröer, C.; Reichard, U.; Eiffert, H.; Scheithauer, S.; Groß, U.; Overmann, J.; Bohne, W. Monitoring microevolution of OXA-48-producing Klebsiella pneumoniae ST147 in a hospital setting by SMRT sequencing. J. Antimicrob. Chemother. 2017, 72, 2737–2744. [Google Scholar] [CrossRef] [Green Version]
  37. Barton, B.M.; Harding, G.P.; Zuccarelli, A.J. A general method for detecting and sizing large plasmids. Anal. Biochem. 1995, 226, 235–240. [Google Scholar] [CrossRef] [PubMed]
  38. Gröbner, S.; Linke, D.; Schütz, W.; Fladerer, C.; Madlung, J.; Autenrieth, I.B.; Witte, W.; Pfeifer, Y. Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany. J. Med. Microbiol. 2009, 58 Pt 7, 912–922. [Google Scholar] [CrossRef] [Green Version]
  39. Pitout, J.D.D.; Peirano, G.; Kock, M.M.; Strydom, K.A.; Matsumura, Y. The Global Ascendency of OXA-48-Type Carbapenemases. Clin. Microbiol. Rev. 2019, 33, e00102–e00119. [Google Scholar] [CrossRef]
  40. Pitout, J.D.; Nordmann, P.; Poirel, L. Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance. Antimicrob. Agents. Chemother. 2015, 59, 5873–5884. [Google Scholar] [CrossRef] [Green Version]
  41. van Duin, D.; Doi, Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence 2017, 8, 460–469. [Google Scholar] [CrossRef] [PubMed]
  42. Lee, C.R.; Lee, J.H.; Park, K.S.; Kim, Y.B.; Jeong, B.C.; Lee, S.H. Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods. Front. Microbiol. 2016, 7, 895. [Google Scholar] [CrossRef] [Green Version]
  43. Sivalingam, P.; Poté, J.; Prabakar, K. Environmental Prevalence of Carbapenem Resistance Enterobacteriaceae (CRE) in a Tropical Ecosystem in India: Human Health Perspectives and Future Directives. Pathogens 2019, 8, 174. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Poirel, L.; Héritier, C.; Tolün, V.; Nordmann, P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2004, 48, 15–22. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Potron, A.; Nordmann, P.; Rondinaud, E.; Jaureguy, F.; Poirel, L. A mosaic transposon encoding OXA-48 and CTX-M-15: Towards pan-resistance. J. Antimicrob. Chemother. 2013, 68, 476–477. [Google Scholar] [CrossRef] [Green Version]
  46. Hua, X.; Zhang, L.; Moran, R.A.; Xu, Q.; Sun, L.; van Schaik, W.; Yu, Y. Cointegration as a mechanism for the evolution of a KPC-producing multidrug resistance plasmid in Proteus mirabilis. Emerg. Microbes Infect. 2020, 9, 1206–1218. [Google Scholar] [CrossRef]
  47. Galimand, M.; Sabtcheva, S.; Courvalin, P.; Lambert, T. Worldwide disseminated armA aminoglycoside resistance methylase gene is borne by composite transposon Tn1548. Antimicrob. Agents Chemother. 2005, 49, 2949–2953. [Google Scholar] [CrossRef] [Green Version]
  48. Uchida, H.; Tada, T.; Tohya, M.; Sugahara, Y.; Kato, A.; Miyairi, I.; Kirikae, T. Emergence in Japan of an isolate of Klebsiella pneumoniae co-harbouring bla(KPC-2) and rmtB. J. Glob. Antimicrob. Resist. 2019, 17, 157–159. [Google Scholar] [CrossRef]
  49. Zurfluh, K.; Power, K.A.; Klumpp, J.; Wang, J.; Fanning, S.; Stephan, R. A novel Tn3-like composite transposon harboring blaVIM-1 in Klebsiella pneumoniae spp. pneumoniae isolated from river water. Microb. Drug Resist. 2015, 21, 43–49. [Google Scholar] [CrossRef]
  50. Huang, J.; Hu, X.; Zhao, Y.; Shi, Y.; Ding, H.; Wu, R.; Zhao, Z.; Ji, J. Comparative Analysis of bla (KPC) Expression in Tn4401 Transposons and the Tn3-Tn4401 Chimera. Antimicrob. Agents Chemother. 2019, 63, e02434-18. [Google Scholar] [CrossRef] [Green Version]
  51. Huang, J.; Hu, X.; Zhao, Y.; Shi, Y.; Ding, H.; Xv, J.; Ren, J.; Wu, R.; Zhao, Z. Genetic Factors Associated with Enhanced blaKPC Expression in Tn3/Tn4401 Chimeras. Antimicrob. Agents. Chemother. 2020, 64, e01836-19. [Google Scholar] [CrossRef] [PubMed]
  52. Fang, L.X.; Li, X.P.; Li, L.; Chen, M.Y.; Wu, C.Y.; Li, L.L.; Liao, X.P.; Liu, Y.H.; Sun, J. ISEcp1-mediated transposition of chromosome-borne bla(CMY-2) into an endogenous ColE1-like plasmid in Escherichia coli. Infect Drug Resist. 2018, 11, 995–1005. [Google Scholar] [CrossRef] [Green Version]
  53. Takemura, H.; Horinouchi, S.; Beppu, T. Novel insertion sequence IS1380 from Acetobacter pasteurianus is involved in loss of ethanol-oxidizing ability. J. Bacteriol. 1991, 173, 7070–7076. [Google Scholar] [CrossRef] [Green Version]
  54. Judd, A.K.; Sadowsky, M.J. The Bradyrhizobium japonicum serocluster 123 hyperreiterated DNA region, HRS1, has DNA and amino acid sequence homology to IS1380, an insertion sequence from Acetobacter pasteurianus. Appl. Environ. Microbiol. 1993, 59, 1656–1661. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Chen, L.; Chavda, K.D.; Fraimow, H.S.; Mediavilla, J.R.; Melano, R.G.; Jacobs, M.R.; Bonomo, R.A.; Kreiswirth, B.N. Complete nucleotide sequences of blaKPC-4- and blaKPC-5-harboring IncN and IncX plasmids from Klebsiella pneumoniae strains isolated in New Jersey. Antimicrob. Agents Chemother. 2013, 57, 269–276. [Google Scholar] [CrossRef] [Green Version]
  56. Lev, A.I.; Astashkin, E.I.; Shaikhutdinova, R.Z.; Platonov, M.E.; Kartsev, N.N.; Volozhantsev, N.V.; Ershova, O.N.; Svetoch, E.A.; Fursova, N.K. Identification of IS1R and IS10R elements inserted into ompk36 porin gene of two multidrug-resistant Klebsiella pneumoniae hospital strains. FEMS Microbiol. Lett. 2017, 364, 10. [Google Scholar] [CrossRef]
  57. Wang, K.; Tian, P. Engineering Plasmid-Free Klebsiella Pneumoniae for Production of 3-Hydroxypropionic Acid. Curr. Microbiol. 2017, 74, 55–58. [Google Scholar] [CrossRef] [PubMed]
  58. Cao, V.; Lambert, T.; Courvalin, P. ColE1-like plasmid pIP843 of Klebsiella pneumoniae encoding extended-spectrum beta-lactamase CTX-M-17. Antimicrob. Agents Chemother. 2002, 46, 1212–1217. [Google Scholar] [CrossRef] [Green Version]
  59. Yi, H.; Xi, Y.; Liu, J.; Wang, J.; Wu, J.; Xu, T.; Chen, W.; Chen, B.; Lin, M.; Wang, H.; et al. Sequence analysis of pKF3-70 in Klebsiella pneumoniae: Probable origin from R100-like plasmid of Escherichia coli. PLoS ONE 2010, 5, e8601. [Google Scholar] [CrossRef]
  60. Chen, C.Y.; Strobaugh, T.P., Jr.; Lindsey, R.L.; Frye, J.G.; Uhlich, G. Sequence analysis of a group of low molecular-weight plasmids carrying multiple IS903 elements flanking a kanamycin resistance aph gene in Salmonella enterica serovars. Plasmid 2011, 65, 246–252. [Google Scholar] [CrossRef]
  61. Adler, A.; Khabra, E.; Chmelnitsky, I.; Giakkoupi, P.; Vatopoulos, A.; Mathers, A.J.; Yeh, A.J.; Sifri, C.D.; De Angelis, G.; Tacconelli, E.; et al. Development and validation of a multiplex PCR assay for identification of the epidemic ST-258/512 KPC-producing Klebsiella pneumoniae clone. Diagn. Microbiol. Infect. Dis. 2014, 78, 12–15. [Google Scholar] [CrossRef]
  62. Wilde, C.; Escartin, F.; Kokeguchi, S.; Latour-Lambert, P.; Lectard, A.; Clément, J.M. Transposases are responsible for the target specificity of IS1397 and ISKpn1 for two different types of palindromic units (PUs). Nucleic Acids Res. 2003, 31, 4345–4353. [Google Scholar] [CrossRef] [Green Version]
  63. Hudson, C.M.; Bent, Z.W.; Meagher, R.J.; Williams, K.P. Resistance determinants and mobile genetic elements of an NDM-1-encoding Klebsiella pneumoniae strain. PLoS ONE 2014, 9, e99209. [Google Scholar]
  64. Zelendova, M.; Papagiannitsis, C.C.; Valcek, A.; Medvecky, M.; Bitar, I.; Hrabak, J.; Gelbicova, T.; Barakova, A.; Kutilova, I.; Karpiskova, R.; et al. Characterization of the Complete Nucleotide Sequences of mcr-1-Encoding Plasmids from Enterobacterales Isolates in Retailed Raw Meat Products From the Czech Republic. Front. Microbiol. 2021, 11, 604067. [Google Scholar] [CrossRef] [PubMed]
  65. Yang, X.; Wai-Chi Chan, E.; Zhang, R.; Chen, S. A conjugative plasmid that augments virulence in Klebsiella pneumoniae. Nat. Microbiol. 2019, 4, 2039–2043. [Google Scholar] [CrossRef]
  66. Giordano, C.; Barnini, S.; Tsioutis, C.; Chlebowicz, M.A.; Scoulica, E.V.; Gikas, A.; Rossen, J.W.; Friedrich, A.W.; Bathoorn, E. Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: The role of ISL3 on plasmids. Int. J. Antimicrob. Agents. 2018, 51, 260–265. [Google Scholar] [CrossRef] [PubMed]
  67. Chen, Q.; Zhou, J.; Wu, S.; Yang, Y.; Yu, D.; Wang, X.; Wu, M. Characterization of the IncX3 Plasmid Producing bla (NDM-7) From Klebsiella pneumoniae ST34. Front. Microbiol. 2020, 11, 1885. [Google Scholar] [CrossRef] [PubMed]
  68. Zankari, E.; Hasman, H.; Cosentino, S.; Vestergaard, M.; Rasmussen, S.; Lund, O.; Aarestrup, F.M.; Larsen, M.V. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 2012, 67, 2640–2644. [Google Scholar] [CrossRef]
  69. Pérez-Vázquez, M.; Oteo, J.; García-Cobos, S.; Aracil, B.; Harris, S.R.; Ortega, A.; Fontanals, D.; Hernández, J.M.; Solís, S.; Campos, J.; et al. Phylogeny, resistome and mobile genetic elements of emergent OXA-48 and OXA-245 Klebsiella pneumoniae clones circulating in Spain. J. Antimicrob. Chemother. 2016, 71, 887–896. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Microorganisms 09 00720 g001 550
Figure 1. Example plasmids found in OXA-48 producing Klebsiella pneumoniae of sequence types ST15 (A,B) and ST101 (C). Plasmids are mapped to possible origins found by National Center for Biotechnology Information (NCBI) BLAST as described in Appendix A Table A1. For ST15 (A,B): (A) Plasmid pKp_Goe_795-2 (CP018461, from Kp_Goe_39795) is mapped to the reference plasmid pOXA-48_L111 (CP030135, query coverage 100%, identity 100%). (B) Plasmid pKp_Goe-795-3 (CP018462, from Kp_Goe_39795) is mapped to the reference plasmid “unnamed3” (CP034056, query coverage 100%, identity 99.98%). (C) For ST101, pKp_Goe208-1 (CP018448, from Kp_Goe_33208,) is mapped to the reference plasmid pKp_Goe_070-1 (CP018451, query coverage 100%, identity 99.99%). Resistance genes as predicted by ResFinder: 1: blaOXA-48, 2: blaOXA-9, 3: blaTEM-1A, 4: blaTEM-1C, 5: tetA, 6: tetD, 7: aac(3)-IIa, 8: aac(6′)-Ib, 9: aadA1, 10: aadA2b, 11:mphA, 12: cmlA1, 13: floR.
Figure 1. Example plasmids found in OXA-48 producing Klebsiella pneumoniae of sequence types ST15 (A,B) and ST101 (C). Plasmids are mapped to possible origins found by National Center for Biotechnology Information (NCBI) BLAST as described in Appendix A Table A1. For ST15 (A,B): (A) Plasmid pKp_Goe_795-2 (CP018461, from Kp_Goe_39795) is mapped to the reference plasmid pOXA-48_L111 (CP030135, query coverage 100%, identity 100%). (B) Plasmid pKp_Goe-795-3 (CP018462, from Kp_Goe_39795) is mapped to the reference plasmid “unnamed3” (CP034056, query coverage 100%, identity 99.98%). (C) For ST101, pKp_Goe208-1 (CP018448, from Kp_Goe_33208,) is mapped to the reference plasmid pKp_Goe_070-1 (CP018451, query coverage 100%, identity 99.99%). Resistance genes as predicted by ResFinder: 1: blaOXA-48, 2: blaOXA-9, 3: blaTEM-1A, 4: blaTEM-1C, 5: tetA, 6: tetD, 7: aac(3)-IIa, 8: aac(6′)-Ib, 9: aadA1, 10: aadA2b, 11:mphA, 12: cmlA1, 13: floR.
Microorganisms 09 00720 g001
Microorganisms 09 00720 g002 550
Figure 2. Example Plasmids found in OXA-48 producing Klebsiella pneumoniae isolates of sequence types ST11. Plasmids are mapped to possible origins found by NCBI BLAST as described in Appendix A Table A1. (A) Plasmid pKp_Goe_588-1 (CP018693, from Kp_Goe_821588) is mapped to pKp_Goe_917-1 (CP018441, query coverage 100%, identity 100%). (B) pKp_Goe_917-3 (CP018442, from Kp_Goe_822917) is mapped to pOW16C2 (KF977034, query coverage 92%, identity 99.99%). Resistance genes as predicted by ResFinder: 1: aph(3′)-Ia, 2: blaOXA-1, 3: blaCTX-M-15, 4: aac(6′)-Ib-cr, 5: aac(3)-IIa, 6: aadA2, 7:mphA, 8: sul1, 9: dfrA12, 10: dfrA14, 11: qacE.
Figure 2. Example Plasmids found in OXA-48 producing Klebsiella pneumoniae isolates of sequence types ST11. Plasmids are mapped to possible origins found by NCBI BLAST as described in Appendix A Table A1. (A) Plasmid pKp_Goe_588-1 (CP018693, from Kp_Goe_821588) is mapped to pKp_Goe_917-1 (CP018441, query coverage 100%, identity 100%). (B) pKp_Goe_917-3 (CP018442, from Kp_Goe_822917) is mapped to pOW16C2 (KF977034, query coverage 92%, identity 99.99%). Resistance genes as predicted by ResFinder: 1: aph(3′)-Ia, 2: blaOXA-1, 3: blaCTX-M-15, 4: aac(6′)-Ib-cr, 5: aac(3)-IIa, 6: aadA2, 7:mphA, 8: sul1, 9: dfrA12, 10: dfrA14, 11: qacE.
Microorganisms 09 00720 g002
Microorganisms 09 00720 g003 550
Figure 3. Plasmid chimaera pKp_Goe_795-1 and possible origins. Plasmid pKp_Goe_795-1 (CP018460) was isolated from strain Kp_Goe_39795 of sequence type ST15. Mapped regions had an identity of >98% with correspondingly colored areas from putative origins and a minimal length of 10 kbp. Regions found include plasmids pHg (CP006662), pKPN39427 (CP054265), pKPN-a68 (CP009777), pH11 (CP013215), as well as two disjointed regions from plasmid incHI2 (LN794248). Resistance genes as predicted by ResFinder: 1: aac(3)-IIa, 2: ant(3″)-Ia, 3: aph(3″)-Ib, 4: aph(6)-Id, 5: blaOXA-1, 6: blaTEM-1B, 7: blaCTX-M-15, 8: aac(6′)-Ib-cr, 9: catA1, 10: catB3, 11: sul2, 12: tetA.
Figure 3. Plasmid chimaera pKp_Goe_795-1 and possible origins. Plasmid pKp_Goe_795-1 (CP018460) was isolated from strain Kp_Goe_39795 of sequence type ST15. Mapped regions had an identity of >98% with correspondingly colored areas from putative origins and a minimal length of 10 kbp. Regions found include plasmids pHg (CP006662), pKPN39427 (CP054265), pKPN-a68 (CP009777), pH11 (CP013215), as well as two disjointed regions from plasmid incHI2 (LN794248). Resistance genes as predicted by ResFinder: 1: aac(3)-IIa, 2: ant(3″)-Ia, 3: aph(3″)-Ib, 4: aph(6)-Id, 5: blaOXA-1, 6: blaTEM-1B, 7: blaCTX-M-15, 8: aac(6′)-Ib-cr, 9: catA1, 10: catB3, 11: sul2, 12: tetA.
Microorganisms 09 00720 g003
Microorganisms 09 00720 g004 550
Figure 4. Summary of the genetic synteny of blaOXA-48, blaCTX-M-14, and blaCTX-M-15 genes on the plasmids of Klebsiella pneumoniae isolates. (A) the locations of blaOXA-48, blaCTX-M-14, and other antimicrobial resistance genes on the pMU407 and pOXA-48 type IncL/M plasmids (B) the locations of blaCTX-M-15 genes on the IncR and IncF type plasmids.
Figure 4. Summary of the genetic synteny of blaOXA-48, blaCTX-M-14, and blaCTX-M-15 genes on the plasmids of Klebsiella pneumoniae isolates. (A) the locations of blaOXA-48, blaCTX-M-14, and other antimicrobial resistance genes on the pMU407 and pOXA-48 type IncL/M plasmids (B) the locations of blaCTX-M-15 genes on the IncR and IncF type plasmids.
Microorganisms 09 00720 g004
Microorganisms 09 00720 g005 550
Figure 5. Comparison of transposons encoding OXA-48. (A) In five of the tested isolates, the blaOXA-48 gene was part of Tn1999; (B) in the two ST101 isolates Kp_Goe_33208 and Kp_Goe_71070 the blaOXA-48 gene was part of a Tn1999.2 transposon, which is characterized by the insertion of IS1R into the upstream IS1999 region.
Figure 5. Comparison of transposons encoding OXA-48. (A) In five of the tested isolates, the blaOXA-48 gene was part of Tn1999; (B) in the two ST101 isolates Kp_Goe_33208 and Kp_Goe_71070 the blaOXA-48 gene was part of a Tn1999.2 transposon, which is characterized by the insertion of IS1R into the upstream IS1999 region.
Microorganisms 09 00720 g005
Table
Table 1. Clinical information available for the seven assessed oxacillinase-48 (OXA-48) producing blaOXA-48-positive Klebsiella pneumoniae isolates from five hospitalized patients in Germany from the blinded analyses. Isolates from the same patient are shaded in identical gray shades.
Table 1. Clinical information available for the seven assessed oxacillinase-48 (OXA-48) producing blaOXA-48-positive Klebsiella pneumoniae isolates from five hospitalized patients in Germany from the blinded analyses. Isolates from the same patient are shaded in identical gray shades.
Sample-IDSequence Type (ST)Patient No. and SexPatient Age at IsolationDate of IsolationSampling LocationUnderlying Medical Condition as Attributed to the Isolate
Kp_Goe_33208ST1011, Male312013-04-05Wound at the perianal locationWound infection
Kp_Goe_71070ST1011, Male312013-04-05UrineUrinary tract infection
Kp_Goe_121641ST1012, Male322013-03-12UrineUrinary tract infection
Kp_Goe_821588ST113, Male502014-02-11Anal regionHygiene assessment (no disease association)
Kp_Goe_822917ST113, Male502013-03-12Hairline on the foreheadHygiene assessment (no disease association)
Kp_Goe_154414ST234, Male362014-07-21Wound at the handAccident-related surgical intervention at the hand
Kp_Goe_39795ST155, Male532014-09-23Tracheal secretionPneumonia
Table
Table 2. Antibiotic susceptibilities of seven OXA-48 producing Klebsiella pneumoniae isolates.
Table 2. Antibiotic susceptibilities of seven OXA-48 producing Klebsiella pneumoniae isolates.
Sample IDPatient No.STPIPTZPCEFATMCTXCAZIPMMEMGENAMKTOBCIPMOXTIGCSTFOSSXT
Kp_Goe_332081101>64>64>32>32>32>32>8>8>8>32>8>2>41≤0.5≤16>160
Kp_Goe_710701101>64>64>32>32>32>32>8>8>8>32>8>2>41≤0.5≤16>160
Kp_Goe_1216412101>64>64>32>32>32>3221>816>8>2>4≤0.5≤0.5≤1640
Kp_Goe_821588311>64>64>32>32>32>3244>88>8>2>42>83240
Kp_Goe_822917311>64>64>32>32>32>3222>84>8>2>42>8≤1640
Kp_Goe_154414423>64>64>32>32>32>324>8>84>8>2>42≤0.512880
Kp_Goe_39795515>64>642>32>32160.51>8≤2>8>2>4>4≤0.56440
Gray shading: resistant. All measured minimum inhibitory concentrations are given in mg/L. Detected resistances (EUCAST v11.0; http://www.eucast.org/clinical_breakpoints, last accessed on 2 December 2021) are shaded in grey. ST, sequence type; PIP, piperacillin; TZP, piperacillin/tazobactam; CEF, cefepime, ATM, aztreonam, CTX, cefotaxime, CAZ, ceftazidime; IPM, imipenem; MEM, meropenem; GEN, gentamicin; AMK, amikacin; TOB, tobramycin; CIP, ciprofloxacin; MOX, moxifloxacin; TIG, tigecycline CST, colistin; FOS, fosfomycin; SXT, trimethoprim-sulfamethoxazole.
Table
Table 3. Detected plasmids, associated antibiotic resistance genes, and detected antibiotic resistances in seven OXA-48 producing Klebsiella pneumoniae isolates.
Table 3. Detected plasmids, associated antibiotic resistance genes, and detected antibiotic resistances in seven OXA-48 producing Klebsiella pneumoniae isolates.
Sample IDDSM No. aAccession NumberCityMLST bPlasmid TypePlasmid Size (Base Pairs)Antibiotic Resistance Genes (ARG)ARG-Associated Mobile Genetic Elements (MGE)Detected Resistance Phenotype
Kp_Goe_33208DSM 103696CP018449SeesenST101IncL/M67,101blaOXA-48Tn1999.2piperacillin, piperacillin/tazobactam, aztreonam, cefotaxime, ceftazidime, gentamicin, tobramycin, amikacin, ciprofloxacin, and moxifloxacin, imipenem, meropenem, amikacin, trimethoprim-sulfamethoxazole
blaCTX-M-14b,
qnrS1, qnrS9,
aph(6)-Id, aph(3′)-VI, aph(3″)		IS6, IS1, IS3 families
CP018448 IncR90,685blaTEM-1A, blaTEM-1C, blaOXA-9, aac(6′)-Ib, aac(6′)-Ib-cr, aac(3)-IIa, ant(3″)-Ia,
tetA, tetD,
mph(A),
cat, cmlA, floR,
dfrA14,
sul3,
emrE,
merE, merT, merC		IS6, IS1, Tn3, Integron IntI pac, IS256, TnpA, IS3
Kp_Goe_71070DSM 103699CP018452SeesenST101IncL/M67,100blaOXA-48Tn1999.2piperacillin, piperacillin/tazobactam, aztreonam, cefotaxime, ceftazidime, gentamicin, tobramycin, amikacin, ciprofloxacin, and moxifloxacin, imipenem, meropenem, amikacin, trimethoprim-sulfamethoxazole
blaCTX-M-14b,
qnrS1, qnrS9,
aph(6)-Id, aph(3′)-VI, aph(3″)		IS6, IS1, IS3 families
CP018451 IncR90,684blaTEM-1A, blaTEM-1C, blaOXA-9, aac(6′)-Ib, aac(6′)-Ib-cr, aac(3)-IIa, ant(3″)-Ia,
tetA, tetD,
mph(A),
cat, cmlA, floR,
dfrA14,
sul3,
emrE,
merE, merT, merC		IS6, IS1, Tn21, Tn3, Integron IntI pac, IS256, TnpA, IS3
Kp_Goe_121641DSM 103707CP018736GöttingenST101IncL/M63,589blaOXA-48Tn1999,
IS1, IS4 families		piperacillin, piperacillin/tazobactam, aztreonam, cefotaxime, ceftazidime, gentamicin, tobramycin, amikacin, ciprofloxacin, moxifloxacin, trimethoprim-sulfamethoxazole
CP018737 IncR72,952blaCTX-M-15, blaOXA-1, blaOXA-9, blaTEM-1A,
ant(3″)-Ia, aac(6′)-Ib, aac(6′)-Ib-cr, aac(3)-IIa,
dfrA14,
cat,
merE, merT, merC		IS6, IS1 (IS1 family ISEcp1 element), Tn21, Tn3, IS256, IS3
Kp_Goe_821588DSM 103700CP018694GöttingenST11IncL/M50,609blaOXA-48Tn1999,
IS1, IS4 families		piperacillin, piperacillin/tazobactam, aztreonam, cefotaxime, ceftazidime, gentamicin, tobramycin, ciprofloxacin, moxifloxacin, trimethoprim-sulfamethoxazole, colistin
CP018693 IncF (FII + FIB)180,027blaCTX-M-15, blaOXA-1,
aac(6′)-Ib-cr, aac(3)-IIa, aph(3′)-Ia, aac(3′)-III
catB3,
dfrA14
Heavy metal (arsenic, copper, cobalt, cobalt, zinc, cadmium) resistance determinantsd		IS903, Tn3, IS6, Integron integrase IntIpac, IS5 (IS1182-DUF772)
Kp_Goe_822917DSM 103702CP018443GöttingenST11IncL/M50,611blaOXA-48Tn1999,
IS1, IS4 families		piperacillin, piperacillin/tazobactam, aztreonam, cefotaxime, ceftazidime, gentamicin, tobramycin, ciprofloxacin, moxifloxacin, trimethoprim-sulfamethoxazole, colistin
CP018441 IncF (FII + FIB)180,027blaCTX-M-15, blaOXA-1,
aac(6′)-Ib-cr, aac(3)-IIa, aph(3′)-Ia, aac(3′)-III
catB3,
dfrA14
Heavy metal (arsenic, copper, cobalt, cobalt, zinc, cadmium) resistance determinantsd		IS903, Tn3, IS6, Integron integrase IntIpac, IS5 (IS1182-DUF772)
CP018442 IncN34,374ant(3″)-Ia,
dfrA(12), sul1,
mph(A),
tetR,
emrE		Tn3, IS6
Kp_Goe_154414DSM 103711CP018342GöttingenST23IncL/M63,588blaOXA-48Tn1999,
IS1, IS4 families		piperacillin, piperacillin/tazobactam, aztreonam, cefotaxime, ceftazidime, gentamicin, tobramycin, ciprofloxacin, and moxifloxacin, meropenem, Fosfomycin, trimethoprim-sulfamethoxazole
CP018338 Inc(FIB)202,175Heavy metal (copper, cobalt, cobalt, zinc, cadmium, tellurium) resistance determinants,
RND efflux protein		IS5, Tn3, IS110, IS3, IS1, Tn21, IS630, IS21, IS66
CP018343 IncF(FII)57,226blaCTX-M-55, blaOXA-1,
aac(3)-IIa, aac(6′)-Ib-cr,
catB3		Tn3, IS6, IS66, IS1, Tn1721 (Tn3), IS3
CP018341 IncFIIK81,641class A β-lactamase (LAP family), qnrS1, catA2,
sul2, tetA		IS3, Tn3, IS6, IS110 le (IS5075), IS91 (TnpA)
CP018340 IncF(FIA)81,939
Kp_Goe_39795DSM 103697CP018461SeesenST15IncL/M63,593blaOXA-48Tn1999,
IS1, IS4 families		piperacillin, piperacillin/tazobactam, aztreonam, cefotaxime, ceftazidime, gentamicin, tobramycin, ciprofloxacin, and moxifloxacin, tigecycline, fosfomycin, trimethoprim-sulfamethoxazole
CP018460 IncF (FIB)232,181blaCTX-M-15, blaOXA-1, blaTEM-1B
aac(6′)-Ib-cr, aac(3)-IIa, aph(6)-Id, aph(3″)-Ib, ant(3″)-Ia,
catB3,
catA1,
sul2,
tetA, tetR,
Heavy metal (arsenic, copper, cobalt, cobalt, zinc, cadmium) resistance determinantsd		IS6, Tn3, Tnp1 (IS1380 le), IS110 le, Integron integrase IntIPac, IS1, ISNCY le, ISL3, IS66, IS3, IS481 le, IS903
CP018462 IncF(FII)32,942tetA, tetRTn3 (Tn1721), Tn3 le, IS6
a deposited at the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH); b Multilocus sequence typing (MLST).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Schwanbeck, J.; Bohne, W.; Hasdemir, U.; Groß, U.; Pfeifer, Y.; Bunk, B.; Riedel, T.; Spröer, C.; Overmann, J.; Frickmann, H.; et al. Detection of a New Resistance-Mediating Plasmid Chimera in a blaOXA-48-Positive Klebsiella pneumoniae Strain at a German University Hospital. Microorganisms 2021, 9, 720. https://doi.org/10.3390/microorganisms9040720

AMA Style

Schwanbeck J, Bohne W, Hasdemir U, Groß U, Pfeifer Y, Bunk B, Riedel T, Spröer C, Overmann J, Frickmann H, et al. Detection of a New Resistance-Mediating Plasmid Chimera in a blaOXA-48-Positive Klebsiella pneumoniae Strain at a German University Hospital. Microorganisms. 2021; 9(4):720. https://doi.org/10.3390/microorganisms9040720

Chicago/Turabian Style

Schwanbeck, Julian, Wolfgang Bohne, Ufuk Hasdemir, Uwe Groß, Yvonne Pfeifer, Boyke Bunk, Thomas Riedel, Cathrin Spröer, Jörg Overmann, Hagen Frickmann, and et al. 2021. "Detection of a New Resistance-Mediating Plasmid Chimera in a blaOXA-48-Positive Klebsiella pneumoniae Strain at a German University Hospital" Microorganisms 9, no. 4: 720. https://doi.org/10.3390/microorganisms9040720

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop